Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
Angiotensin II mechanisms merit targeted arrhythmia trials; should not yet change clinical practice.
In the recent years, a tremendous amount has been learned about the pathophysiology and molecular biology of the cardiac angiotensin II system. Interestingly, the angiotensin II appears to have several effects on cardiac electrophysiology, which have not been fully appreciated so far. Therefore, this review will highlight on the basic knowledge of signal transduction and electrophysiological effects of angiotensin II, which may have an impact on the occurrence of cardiac arrhythmia.
No takes yet. Share an insight, caveat, or question.
Goette et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: